Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Marex Group plc (MRX) : This financial services platform provider has seen the Zacks Consensus Estimate for its current year earnings increasing 22.3% over the last 60 days.AngioDynamics, Inc. (ANGO) : This medical technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.8% over the last 60 days.Opera Limited (OPRA) : This internet technology company has seen the Zacks Consensus Estimate for i ...

AngioDynamics, Inc.(ANGO) has initiated the RECOVER-AV clinical trial, a prospective, multinational, single-arm study aimed at assessing the efficacy, safety and long-term outcomes of the AlphaVac Multipurpose Mechanical Aspiration F1885 System for treating acute intermediate-risk pulmonary embolism (PE).Following the success of the U.S.-based APEX-AV trial, which demonstrated significant improvements in right ventricular function and clot burden reduction, RECOVER-AV will enroll patients across 20 European ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Arcturus Therapeutics Holdings Inc. (ARCT) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 40.8% over the last 60 days.M/I Homes, Inc. (MHO) : This homebuilder company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.7% over the last 60 days.First Mid Bancshares, Inc. (FMBH) : This financial holding company has seen the Zacks Consensus Estimate f ...

AngioDynamics, Inc. (ANGO) has announced that its Auryon Atherectomy System has received the CE Mark. This innovative system, designed for the treatment of Peripheral Artery Disease (PAD), including Critical Limb Ischemia (CLI) and In-Stent Restenosis (ISR), utilizes state-of-the-art solid-state laser technology. It stands out as the first laser atherectomy system capable of treating lesions of any type, length, or location with minimal vessel wall impact.AngioDynamics is a pioneering medical technology com ...

AngioDynamics (ANGO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a ...

AngioDynamics (ANGO) closed the last trading session at $7.53, gaining 0.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $13.33 indicates a 77% upside potential.The average comprises three short-term price targets ranging from a low of $13 to a high of $14, with a standard deviation of $0.58. While the lowest estimate indicates an increase of 72.6% from the current price level, ...

From a technical perspective, AngioDynamics, Inc. (ANGO) is looking like an interesting pick, as it just reached a key level of support. ANGO's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.Considered an important signifier for a bullish breakout, a golden cross is a technical chart pattern that's formed when a stock's short-term moving average breaks above a longer-term moving average; the most common crossover involves ...

Shares of AngioDynamics (ANGO) have gained 26.5% over the past four weeks to close the last trading session at $7.65, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.33 indicates a potential upside of 74.3%.The average comprises three short-term price targets ranging from a low of $13 to a high of $14, with a standard deviation of $0.58. While the lowest estimate indicates a ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Kronos Worldwide, Inc. (KRO) : This titanium dioxide pigment company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.9% over the last 60 days.First United Corporation (FUNC) : This bank holding company for First United Bank & Trust has seen the Zacks Consensus Estimate for its current year earnings increasing 9.1% over the last 60 days.PROG Holdings, Inc. (PRG) : This financial technology holding compan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |-----------------------------------------------------------------------|----------------------------------------------------------------------------------|---------------------------- ...